4-((9-Chloro-7-(2-Fluoro-6-Methoxyphenyl)-5H-Benzo[C]Pyrimido[4,5-E]Azepin-2-Yl)Amino)-2-Methoxybenzoic Acid

Alisertib is primarily investigated for its application in oncology as a treatment for various malignancies characterized by dysregulated Aurora A kinase activity. Clinical trials have shown promising results in treating hematological malignancies and solid tumors, with ongoing studies assessing its efficacy in combination with other therapeutic agents . Additionally, it is being explored for its potential role in overcoming drug resistance mechanisms in cancer therapy .

Alisertib exhibits potent anti-cancer activity through its selective inhibition of Aurora A kinase. This inhibition leads to cell cycle arrest and apoptosis in cancer cells. Studies have demonstrated that alisertib induces apoptosis by activating mitochondrial pathways and inhibiting critical signaling cascades such as the p38 mitogen-activated protein kinase/phosphoinositide-3 kinase/Akt/mammalian target of rapamycin pathway . Furthermore, it has been shown to promote autophagy in certain cancer cell lines, enhancing its therapeutic efficacy .

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.